STOCK TITAN

Nano-X Imaging: YA II reports 9.9% ownership

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

Nano-X Imaging Ltd. (NNOX) shares were reported as beneficially owned by YA II PN, Ltd. and six affiliated reporting persons: YA Global Investments II (U.S.), LP (YA II’s beneficial owner), Yorkville Advisors Global, LP (investment manager), Yorkville Advisors Global II, LLC (general partner to the manager), YAII GP, LP (general partner to YA Global Investments II), YAII GP II, LLC (general partner to YAII GP), and Mark Angelo (who makes YA II’s investment decisions). The reported amount was 8,638,180 ordinary shares, or 9.9%, with shared voting and dispositive power; these are overlapping attributions, not separate holdings.

The percentage calculation used 86,468,270 shares: 78,747,008 outstanding as of November 12, 2026, plus 7,721,262 that may be issued to YA II. The Resale SEPA is for up to $40 million and the Primary SEPA for up to $10 million. Under the agreements, Nano-X may issue and sell up to $50 million of ordinary shares to YA II, subject to their terms and conditions, and issuance is barred if it would cause YA II and its affiliates to exceed 9.99% of then-outstanding shares.

Beneficial ownership 8,638,180 ordinary shares Reported by YA II PN, Ltd. and affiliated reporting persons
Percent of class 9.9% Reported beneficial ownership
Resale SEPA Up to $40 million Ordinary shares under the agreement
Primary SEPA Up to $10 million Ordinary shares under the agreement
Combined SEPA issuance limit Up to $50 million Ordinary shares Nano-X may issue and sell to YA II
Shares outstanding 78,747,008 ordinary shares As of November 12, 2026
Potentially issuable shares 7,721,262 ordinary shares May be issued to YA II; included in the ownership-percentage calculation
Beneficial ownership limit 9.99% Issuance is prohibited to the extent it would cause YA II and its affiliates to exceed this share of then-outstanding ordinary shares
beneficially owned financial
"aggregate number of ordinary shares then beneficially owned by YA II and its affiliates"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
shared voting power financial
"Shared voting power 8,638,180"
Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.
shared dispositive power financial
"Shared dispositive power 8,638,180"
Standby Equity Distribution Agreement financial
"Standby Equity Distribution Agreement (the “Resale SEPA”)"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many NNOX shares did YA II report beneficially owning?

YA II PN, Ltd. reported beneficial ownership of 8,638,180 Nano-X ordinary shares, or 9.9%. The affiliated reporting persons reported the same amount with shared voting and dispositive power, so these are overlapping attributions rather than additional share blocks.

What are the terms of Nano-X’s SEPA agreements with YA II?

The Resale SEPA is for up to $40 million of ordinary shares, and the Primary SEPA is for up to $10 million. Both agreements were entered into on November 12, 2026. Nano-X has the option to issue and sell up to $50 million of shares to YA II, which is obligated to purchase them at the price and on the terms and conditions set out in the agreements. The agreements limit issuance if it would cause YA II and its affiliates to exceed 9.99% of then-outstanding shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





M70700105

(CUSIP Number)
11/12/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: Based on 86,468,270 ordinary shares, consisting of 78,747,008 ordinary shares outstanding as of November 12, 2026, plus an additional 7,721,262 ordinary shares that may be issued to YA II PN, Ltd. ("YA II") pursuant to the Standby Equity Distribution Agreement (the "Resale SEPA") for up to $40 million of ordinary shares, and the Standby Equity Distribution Agreement (the "Primary SEPA" and collectively with the Resale SEPA, the "SEPA") for up to $10 million of ordinary shares, each entered into on November 12, 2026 between YA II and Nano-X Imaging Ltd. (the "Issuer").


SCHEDULE 13G




Comment for Type of Reporting Person: Based on 86,468,270 ordinary shares, consisting of 78,747,008 ordinary shares outstanding as of November 12, 2026, plus an additional 7,721,262 ordinary shares that may be issued to YA II PN, Ltd. ("YA II") pursuant to the Standby Equity Distribution Agreement (the "Resale SEPA") for up to $40 million of ordinary shares, and the Standby Equity Distribution Agreement (the "Primary SEPA" and collectively with the Resale SEPA, the "SEPA") for up to $10 million of ordinary shares, each entered into on November 12, 2026 between YA II and Nano-X Imaging Ltd. (the "Issuer").


SCHEDULE 13G




Comment for Type of Reporting Person: Based on 86,468,270 ordinary shares, consisting of 78,747,008 ordinary shares outstanding as of November 12, 2026, plus an additional 7,721,262 ordinary shares that may be issued to YA II PN, Ltd. ("YA II") pursuant to the Standby Equity Distribution Agreement (the "Resale SEPA") for up to $40 million of ordinary shares, and the Standby Equity Distribution Agreement (the "Primary SEPA" and collectively with the Resale SEPA, the "SEPA") for up to $10 million of ordinary shares, each entered into on November 12, 2026 between YA II and Nano-X Imaging Ltd. (the "Issuer").


SCHEDULE 13G




Comment for Type of Reporting Person: Based on 86,468,270 ordinary shares, consisting of 78,747,008 ordinary shares outstanding as of November 12, 2026, plus an additional 7,721,262 ordinary shares that may be issued to YA II PN, Ltd. ("YA II") pursuant to the Standby Equity Distribution Agreement (the "Resale SEPA") for up to $40 million of ordinary shares, and the Standby Equity Distribution Agreement (the "Primary SEPA" and collectively with the Resale SEPA, the "SEPA") for up to $10 million of ordinary shares, each entered into on November 12, 2026 between YA II and Nano-X Imaging Ltd. (the "Issuer").


SCHEDULE 13G




Comment for Type of Reporting Person: Based on 86,468,270 ordinary shares, consisting of 78,747,008 ordinary shares outstanding as of November 12, 2026, plus an additional 7,721,262 ordinary shares that may be issued to YA II PN, Ltd. ("YA II") pursuant to the Standby Equity Distribution Agreement (the "Resale SEPA") for up to $40 million of ordinary shares, and the Standby Equity Distribution Agreement (the "Primary SEPA" and collectively with the Resale SEPA, the "SEPA") for up to $10 million of ordinary shares, each entered into on November 12, 2026 between YA II and Nano-X Imaging Ltd. (the "Issuer").


SCHEDULE 13G




Comment for Type of Reporting Person: Based on 86,468,270 ordinary shares, consisting of 78,747,008 ordinary shares outstanding as of November 12, 2026, plus an additional 7,721,262 ordinary shares that may be issued to YA II PN, Ltd. ("YA II") pursuant to the Standby Equity Distribution Agreement (the "Resale SEPA") for up to $40 million of ordinary shares, and the Standby Equity Distribution Agreement (the "Primary SEPA" and collectively with the Resale SEPA, the "SEPA") for up to $10 million of ordinary shares, each entered into on November 12, 2026 between YA II and Nano-X Imaging Ltd. (the "Issuer").


SCHEDULE 13G




Comment for Type of Reporting Person: Based on 86,468,270 ordinary shares, consisting of 78,747,008 ordinary shares outstanding as of November 12, 2026, plus an additional 7,721,262 ordinary shares that may be issued to YA II PN, Ltd. ("YA II") pursuant to the Standby Equity Distribution Agreement (the "Resale SEPA") for up to $40 million of ordinary shares, and the Standby Equity Distribution Agreement (the "Primary SEPA" and collectively with the Resale SEPA, the "SEPA") for up to $10 million of ordinary shares, each entered into on November 12, 2026 between YA II and Nano-X Imaging Ltd. (the "Issuer").


SCHEDULE 13G



YA II PN, Ltd.
Signature:/s/ David Gonzalez
Name/Title:David Gonzalez, General Counsel
Date:11/13/2026
YA Global Investments II (U.S.), LP
Signature:/s/ David Gonzalez
Name/Title:David Gonzalez, General Counsel
Date:11/13/2026
Yorkville Advisors Global, LP
Signature:/s/ David Gonzalez
Name/Title:David Gonzalez, General Counsel
Date:11/13/2026
Yorkville Advisors Global II, LLC
Signature:/s/ David Gonzalez
Name/Title:David Gonzalez, General Counsel
Date:11/13/2026
YAII GP, LP
Signature:/s/ David Gonzalez
Name/Title:David Gonzalez, General Counsel
Date:11/13/2026
YAII GP II, LLC
Signature:/s/ David Gonzalez
Name/Title:David Gonzalez, General Counsel
Date:11/13/2026
Mark Angelo
Signature:/s/ Mark Angelo
Name/Title:Mark Angelo
Date:11/13/2026

Keep reading